2099.5000 -33.00 (-1.55%)
NSE Sep 15, 2025 15:31 PM
Volume: 546.8K
 

2099.50
-1.55%
Reliance Securities
ff US Biz (31% of Sales): US base business declined by 27.1% YoY to US$109mn due to higher price erosion and large YoY base owing to gZetia contribution. GNP expects price erosion, which stood at 12% in 4QFY18, to remain in FY19E. The Company intends to launch 10-12 products (including limited-competition products) in FY19E. Cumulatively, it filed 193 ANDAs, out of which 62 are pending for approvals (including Para-IV: 26). Indore plant has received...
Number of FII/FPI investors decreased from 404 to 396 in Jun 2025 qtr
More from Glenmark Pharmaceuticals Ltd.
Recommended